Concurrent use of e-cigarettes and cannabis and associated COVID-19 symptoms, testing, and diagnosis among student e-cigarette users at four U. S. Universities

被引:7
|
作者
Merianos, Ashley L. [1 ]
Russell, Alex M. [2 ]
Mahabee-Gittens, E. Melinda [3 ]
Barry, Adam E. [4 ]
Yang, Meng [5 ]
Lin, Hsien-Chang [5 ]
机构
[1] Univ Cincinnati, Sch Human Serv, POB 210068, Cincinnati, OH 45221 USA
[2] Univ Arkansas, Dept Hlth Human Performance & Recreat, 308 HPER Bldg, Fayetteville, AR 72703 USA
[3] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Coll Med, Div Emergency Med, Cincinnati, OH 45229 USA
[4] Texas A&M Univ, Dept Hlth & Kinesiol, College Stn, TX 77843 USA
[5] Indiana Univ, Dept Appl Hlth Sci, Sch Publ Hlth Bloomington, Bloomington, IN 47405 USA
关键词
Electronic nicotine delivery systems; Cannabis use; College students; LUNG INJURY; MARIJUANA; SMOKING; ADULTS;
D O I
10.1016/j.addbeh.2021.107170
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Introduction: This investigation assessed whether current (past 30-day) electronic cigarette (e-cigarette) and cannabis use was associated with coronavirus disease 2019 (COVID-19) symptomatology, testing, and diagnosis among college student e-cigarette users. Methods: Participants were 18-26-year-old college student e-cigarette users attending four geographically diverse, large U.S. public universities during October-December 2020 (N = 800). Multivariable logistic regression models explored associations between exclusive e-cigarette use and concurrent e-cigarette and cannabis use and COVID-19 symptoms, testing, and diagnosis. Models controlled for demographics, university site, and current use of combustible cigarettes, cigars, and smokeless tobacco. Results: Over half of student e-cigarette users (52.0%) concurrently used cannabis. Compared to exclusive e-cigarette users, concurrent e-cigarette and cannabis users were 3.53 times more likely (95%CI = 1.96-6.36) to report COVID-19 symptoms, after adjusting for the covariates. Compared to infrequent exclusive e-cigarette users, infrequent concurrent users (AOR = 4.72, 95%CI = 1.31-17.00), intermediate concurrent users (AOR = 5.10, 95%CI = 1.37-18.97), and frequent concurrent users (AOR = 7.44, 95%CI = 2.06-26.84) were at increased odds of reporting COVID-19 symptoms. Compared to exclusive e-cigarette users, concurrent e-cigarette and cannabis users were 1.85 times more likely (95%CI = 1.15-2.98) to report a COVID-19 diagnosis. Intermediate concurrent users (AOR = 2.88, 95%CI = 1.13-7.35) and frequent concurrent users (AOR = 3.22, 95%CI = 1.32-7.87) were at increased odds of reporting a COVID-19 diagnosis, compared to infrequent exclusive e-cigarette users. Conclusions: Concurrent use of e-cigarettes and cannabis may be an underlying risk factor of COVID-19 symptomatology and diagnosis, with more pronounced odds found among intermediate and frequent users. Results highlight the need to educate students about the impacts of e-cigarette and cannabis use on respiratory, immune, and overall health.
引用
下载
收藏
页数:8
相关论文
共 11 条
  • [11] Vaping in today's pandemic: E-cigarette, or vaping, product use-associated lung injury mimicking COVID-19 in teenagers presenting with respiratory distress
    Darmawan, Daphne O.
    Gwal, Kriti
    Goudy, Brian D.
    Jhawar, Sanjay
    Nandalike, Kiran
    SAGE OPEN MEDICAL CASE REPORTS, 2020, 8